Given the panoply of positive actions of PON1, pharmacological and nutritional modulation of PON1 activity and/or gene expression could constitute a useful approach to the prevention of cardiovascular and other diseases, such as diabetes, Alzheimer’s disease, chronic renal failure, and chronic liver impairment [15]. The gene discussed is PON1; the disease is early-onset autosomal dominant Alzheimer disease.